Foghorn Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Foghorn Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | FHTX | Q1 | -$0.73 | -$0.68 | — | — | $5.31M | $6.91M | — | — | Get Alert |
03/07/2024 | AM | FHTX | Q4 | -$0.69 | -$0.76 | -$0.57 | 25.00% | $4.18M | $4.62M | $5.77M | 24.87% | Get Alert |
11/02/2023 | AM | FHTX | Q3 | -$0.62 | -$0.75 | -$0.34 | 54.67% | $6.63M | $4.52M | $17.48M | 286.68% | Get Alert |
08/04/2023 | AM | FHTX | Q2 | -$0.66 | -$0.73 | -$0.70 | 4.11% | $4.49M | $6.26M | $5.60M | -10.56% | Get Alert |
05/08/2023 | AM | FHTX | Q1 | -$0.65 | -$0.72 | -$0.73 | -1.39% | $3.92M | $5.04M | $5.31M | 5.34% | Get Alert |
03/09/2023 | AM | FHTX | Q4 | -$0.77 | -$0.62 | -$0.69 | -11.29% | $713.00K | $8.48M | $4.18M | -50.66% | Get Alert |
11/08/2022 | AM | FHTX | Q3 | -$0.71 | -$0.62 | -$0.62 | 0.00% | $41.00K | $9.20M | $6.63M | -27.89% | Get Alert |
08/09/2022 | AM | FHTX | Q2 | -$0.63 | -$0.59 | -$0.66 | -11.86% | $279.00K | $8.69M | $4.49M | -48.33% | Get Alert |
05/09/2022 | AM | FHTX | Q1 | -$0.62 | — | -$0.65 | — | $286.00K | — | $3.92M | — | Get Alert |
03/10/2022 | AM | FHTX | Q4 | $2.53 | -$0.74 | -$0.77 | -4.05% | $251.00K | $330.00K | $713.00K | 116.06% | Get Alert |
11/09/2021 | AM | FHTX | Q3 | -$3.12 | — | -$0.71 | — | $179.00K | — | $41.00K | — | Get Alert |
08/10/2021 | AM | FHTX | Q2 | — | — | -$0.63 | — | — | — | $279.00K | — | Get Alert |
05/11/2021 | AM | FHTX | Q1 | — | — | -$0.62 | — | — | — | $286.00K | — | Get Alert |
03/18/2021 | AM | FHTX | Q4 | — | — | $2.53 | — | — | — | $251.00K | — | Get Alert |
12/04/2020 | AM | FHTX | Q3 | — | — | -$3.12 | — | — | — | $179.00K | — | Get Alert |
Foghorn Therapeutics (FHTX) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 7, 2024 for Q4.
The Actual EPS was $-0.57, which beat the estimate of $-0.76.
The Actual Revenue was $5.8M, which beat the estimate of $4.6M.
Browse earnings estimates, EPS, and revenue on all stocks.